RUA Life Sciences (LON:RUA) Stock Price Down 10.9% – Here’s What Happened

RUA Life Sciences plc (LON:RUAGet Free Report)’s share price fell 10.9% during mid-day trading on Friday . The stock traded as low as GBX 14.03 and last traded at GBX 14.03. 601,581 shares traded hands during trading, an increase of 128% from the average session volume of 263,286 shares. The stock had previously closed at GBX 15.75.

RUA Life Sciences Stock Down 7.4%

The company has a market capitalization of £9.05 million, a PE ratio of -2.61 and a beta of 1.21. The stock’s fifty day moving average is GBX 13.06 and its two-hundred day moving average is GBX 12.02. The company has a current ratio of 9.01, a quick ratio of 7.32 and a debt-to-equity ratio of 5.42.

RUA Life Sciences (LON:RUAGet Free Report) last announced its quarterly earnings data on Friday, January 30th. The company reported GBX (0.23) EPS for the quarter. RUA Life Sciences had a negative return on equity of 26.38% and a negative net margin of 65.72%.

RUA Life Sciences Company Profile

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Further Reading

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.